4 Results for "

Sorbitol (Standard)

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Sorbitol (Standard)" in MCE Product Catalog:

Cat. No.: HY-B0400R
CAS No.: 50-70-4
Synonyms: Sorbitol (Standard); D-Glucitol (Standard)
D-Sorbitol (Standard) is the analytical standard of D-Sorbitol. This product is intended for research and analytical applications. D-Sorbitol (Sorbitol) is a six-carbon sugar alcohol and can used as a sugar substitute. D-Sorbitol can be used as a stabilizing excipient and/or isotonicity agent, sweetener, humectant, thickener and dietary supplement .
loading...
    loading...
Cat. No.: HY-50289R
CAS No.: 68367-52-2
Target:  

Aldose Reductase

Research Areas:  

Metabolic Disease

Sorbinil (Standard) is the analytical standard of Sorbinil. This product is intended for research and analytical applications. Sorbinil is an aldose reductase inhibitor (ARI) that prevents the accumulation of sorbitol in cells or animals. Sorbinil is useful in studying diabetes and diabetic complications, reducing AR activity and inhibiting the polyol pathway .
loading...
    loading...
Cat. No.: HY-B0342R
CAS No.: 6284-40-8
Synonyms: Methylglucamine (Standard); Meglumin (Standard); Methylglucamin (Standard)
Research Areas:  

Cancer

Meglumine (Standard) is the analytical standard of Meglumine. This product is intended for research and analytical applications. Meglumine (Methylglucamine) is an orally active amino sugar derived from sorbitol. Meglumine has anti-inflammatory and antitumor activity. Meglumine is often used as an excipient in active molecules and with iodinated compounds in contrast agents such as meglumine and meglumine iodide .
loading...
    loading...
Cat. No.: HY-106697R
CAS No.: 72702-95-5
Synonyms: ICI 128436 (Standard)
Research Areas:  

Metabolic Disease

Ponalrestat (Standard) (ICI 128436 (Standard)) is the analytical standard of Ponalrestat (HY-106697). This product is intended for research and analytical applications. Ponalrestat (ICI 128436) is an orally active, selective and noncompetitive aldose reductase (AKR1B1; ALR) inhibitor. Ponalrestat selectively inhibits ALR2 (Ki=7.7 nM) over ALR1 (Ki=60 μM). Ponalrestat inhibits the conversion of glucose to sorbitol .
loading...
    loading...